Literature DB >> 7000468

Prostaglandins, kinins and the regulation of blood pressure.

J C McGiff, J Quilley.   

Abstract

Prostaglandins participate in the regulation of vascular reactivity and blood pressure by opposing the vasoconstrictor and antinatriuretic actions of pressor hormones, and by moderating the release of norepinephrine from vasoconstrictor nerves. Blood vessels synthesize prostaglandins intramurally, where their local release influences vascular reactivity. PGI2, unlike PGE2, may be a circulating hormone and may influence vascular resistance of organs remote from its site of synthesis. Prostaglandins not only attenuate the effects of vasoconstrictor hormones but also amplify the effects of the kallikrein-kinin system intrarenally and within the vasculature.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000468     DOI: 10.3109/10641968009037139

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 0148-3927            Impact factor:   1.749


  5 in total

1.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

2.  Correction of altered noradrenaline reactivity in essential hypertension by indapamide.

Authors:  M Grimm; P Weidmann; A Meier; G Keusch; W Ziegler; Z Glück; C Beretta-Piccoli
Journal:  Br Heart J       Date:  1981-10

3.  Captopril for refractory hypertension in patients with impaired renal function.

Authors:  M S Laher; P O'Regan; J F O'Donohoe; T B Counihan
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

4.  Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.

Authors:  K Silberbauer; B Stanek; H Templ
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 5.  Function and structure of bradykinin receptor 2 for drug discovery.

Authors:  Jin-Kang Shen; Hai-Tao Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-09-08       Impact factor: 7.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.